Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paolo Antonio S. Silva, M.D.

Co-Author

This page shows the publications co-authored by Paolo Silva and Lloyd Aiello.
Connection Strength

10.243
  1. Hemorrhage and/or Microaneurysm Severity and Count in Ultrawide Field Images and Early Treatment Diabetic Retinopathy Study Photography. Ophthalmology. 2017 07; 124(7):970-976.
    View in: PubMed
    Score: 0.702
  2. Identification of Diabetic Retinopathy and Ungradable Image Rate with Ultrawide Field Imaging in a National Teleophthalmology Program. Ophthalmology. 2016 06; 123(6):1360-7.
    View in: PubMed
    Score: 0.653
  3. Comparison of Nondiabetic Retinal Findings Identified With Nonmydriatic Fundus Photography vs Ultrawide Field Imaging in an Ocular Telehealth Program. JAMA Ophthalmol. 2016 Mar; 134(3):330-4.
    View in: PubMed
    Score: 0.653
  4. Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography. Ophthalmology. 2015 Dec; 122(12):2465-72.
    View in: PubMed
    Score: 0.631
  5. Real-Time Ultrawide Field Image Evaluation of Retinopathy in a Diabetes Telemedicine Program. Diabetes Care. 2015 Sep; 38(9):1643-9.
    View in: PubMed
    Score: 0.620
  6. Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes. JAMA Ophthalmol. 2015 May; 133(5):525-6.
    View in: PubMed
    Score: 0.616
  7. Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years. Ophthalmology. 2015 May; 122(5):949-56.
    View in: PubMed
    Score: 0.608
  8. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014 Oct; 34(10):1960-8.
    View in: PubMed
    Score: 0.592
  9. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014; 37(1):50-5.
    View in: PubMed
    Score: 0.547
  10. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology. 2013 Dec; 120(12):2587-2595.
    View in: PubMed
    Score: 0.541
  11. Comparison of low-light nonmydriatic digital imaging with 35-mm ETDRS seven-standard field stereo color fundus photographs and clinical examination. Telemed J E Health. 2012 Sep; 18(7):492-9.
    View in: PubMed
    Score: 0.509
  12. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012 Sep; 154(3):549-559.e2.
    View in: PubMed
    Score: 0.503
  13. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol. 2011 Feb; 129(2):236-42.
    View in: PubMed
    Score: 0.459
  14. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 2010 Sep; 6(9):494-508.
    View in: PubMed
    Score: 0.443
  15. Ocular telehealth initiatives in diabetic retinopathy. Curr Diab Rep. 2009 Aug; 9(4):265-71.
    View in: PubMed
    Score: 0.414
  16. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin Ophthalmol. 2009 Mar-Apr; 24(2):93-9.
    View in: PubMed
    Score: 0.402
  17. Automated retinal image analysis for diabetic retinopathy in telemedicine. Curr Diab Rep. 2015 Mar; 15(3):14.
    View in: PubMed
    Score: 0.152
  18. Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema. Diabetes. 2015 Jul; 64(7):2560-70.
    View in: PubMed
    Score: 0.151
  19. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014 Nov; 132(11):1309-16.
    View in: PubMed
    Score: 0.149
  20. Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion. Eye (Lond). 2014 Mar; 28(3):259-68.
    View in: PubMed
    Score: 0.142
  21. Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med. 2012 Jun; 2(6):a006411.
    View in: PubMed
    Score: 0.126
  22. Automated Retinal Imaging System (ARIS) compared with ETDRS protocol color stereoscopic retinal photography to assess level of diabetic retinopathy. Diabetes Technol Ther. 2012 Jun; 14(6):515-22.
    View in: PubMed
    Score: 0.124
  23. Imager evaluation of diabetic retinopathy at the time of imaging in a telemedicine program. Diabetes Care. 2012 Mar; 35(3):482-4.
    View in: PubMed
    Score: 0.123
  24. Ocular telemedicine for diabetic retinopathy and the Joslin Vision Network. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):218-24.
    View in: PubMed
    Score: 0.112
  25. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010 Jun; 117(6):1064-1077.e35.
    View in: PubMed
    Score: 0.109
  26. Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. 2011 Aug 03; 52(9):6168-73.
    View in: PubMed
    Score: 0.059
  27. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015 Mar 26; 372(13):1193-203.
    View in: PubMed
    Score: 0.038
  28. Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy. Diabetologia. 2013 Jun; 56(6):1444-53.
    View in: PubMed
    Score: 0.033
  29. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012 Sep-Nov; 27(5-6):221-7.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.